Viewing Study NCT00520416



Ignite Creation Date: 2024-05-05 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00520416
Status: COMPLETED
Last Update Posted: 2017-03-17
First Post: 2007-08-22

Brief Title: Prospective Non-Randomized Evaluation of Carbon Dioxide Gas as a Contrast Agent in Comparison With Iodinated Contrast in Endovascular Aneurysm Repair
Sponsor: University of Southern California
Organization: University of Southern California

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2017-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Endovascular repair of infrarenal abdominal aortic aneurysms AAA requires a contrast agent to identify the vascular anatomy and placement of the stent graft Iodine contrast has traditionally been used but has the potential to harm the kidneys Another contrast agent is carbon dioxide gas It has been proven safe to use but the quality of the images it creates needs to be compared to iodine contrast Patients in this study undergo the endovascular AAA repair as they normally with the iodine contrast At the end of surgery carbon dioxide gas contrast is given as an extra step The images will be later evaluated
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None